Jun 24, 2025 12:30
IBO - Impact BioMedical, Inc.
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 0.45 0.0 (1.08%) | --- | --- | --- | 0.0 (0.0%) | 0.0 (1.1%) | 0.0 (0.0%) | 0.01 (2.39%) |
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- -1.18
- Diluted EPS:
- -1.18
- Basic P/E:
- -0.3856
- Diluted P/E:
- -0.3856
- RSI(14) 1m:
- 0.0
- VWAP:
- 0.46
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Mar 21, 2025 18:38
Feb 26, 2025 13:30
Dec 12, 2024 20:56
Oct 25, 2024 11:00
Oct 15, 2024 10:00
Sep 17, 2024 15:29